Chapter/Section Purchase

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global 3D Bioprinting Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Magnetic 3D Bioprinting
1.2.3 Laser-assisted Bioprinting
1.2.4 Inkjet 3D Bioprinting
1.2.5 Microextrusion 3D Bioprinting
1.3 Market by Application
1.3.1 Global 3D Bioprinting Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Clinical Applications
1.3.3 Research Applications
1.3.4 Drug and Medical Research
1.3.5 Regenerative Medicine
1.3.6 3D Cell Culture
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global 3D Bioprinting Market Perspective (2017-2028)
2.2 3D Bioprinting Growth Trends by Region
2.2.1 3D Bioprinting Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 3D Bioprinting Historic Market Size by Region (2017-2022)
2.2.3 3D Bioprinting Forecasted Market Size by Region (2023-2028)
2.3 3D Bioprinting Market Dynamics
2.3.1 3D Bioprinting Industry Trends
2.3.2 3D Bioprinting Market Drivers
2.3.3 3D Bioprinting Market Challenges
2.3.4 3D Bioprinting Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top 3D Bioprinting Players by Revenue
3.1.1 Global Top 3D Bioprinting Players by Revenue (2017-2022)
3.1.2 Global 3D Bioprinting Revenue Market Share by Players (2017-2022)
3.2 Global 3D Bioprinting Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by 3D Bioprinting Revenue
3.4 Global 3D Bioprinting Market Concentration Ratio
3.4.1 Global 3D Bioprinting Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by 3D Bioprinting Revenue in 2021
3.5 3D Bioprinting Key Players Head office and Area Served
3.6 Key Players 3D Bioprinting Product Solution and Service
3.7 Date of Enter into 3D Bioprinting Market
3.8 Mergers & Acquisitions, Expansion Plans
4 3D Bioprinting Breakdown Data by Type
4.1 Global 3D Bioprinting Historic Market Size by Type (2017-2022)
4.2 Global 3D Bioprinting Forecasted Market Size by Type (2023-2028)
5 3D Bioprinting Breakdown Data by Application
5.1 Global 3D Bioprinting Historic Market Size by Application (2017-2022)
5.2 Global 3D Bioprinting Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America 3D Bioprinting Market Size (2017-2028)
6.2 North America 3D Bioprinting Market Size by Type
6.2.1 North America 3D Bioprinting Market Size by Type (2017-2022)
6.2.2 North America 3D Bioprinting Market Size by Type (2023-2028)
6.2.3 North America 3D Bioprinting Market Share by Type (2017-2028)
6.3 North America 3D Bioprinting Market Size by Application
6.3.1 North America 3D Bioprinting Market Size by Application (2017-2022)
6.3.2 North America 3D Bioprinting Market Size by Application (2023-2028)
6.3.3 North America 3D Bioprinting Market Share by Application (2017-2028)
6.4 North America 3D Bioprinting Market Size by Country
6.4.1 North America 3D Bioprinting Market Size by Country (2017-2022)
6.4.2 North America 3D Bioprinting Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe 3D Bioprinting Market Size (2017-2028)
7.2 Europe 3D Bioprinting Market Size by Type
7.2.1 Europe 3D Bioprinting Market Size by Type (2017-2022)
7.2.2 Europe 3D Bioprinting Market Size by Type (2023-2028)
7.2.3 Europe 3D Bioprinting Market Share by Type (2017-2028)
7.3 Europe 3D Bioprinting Market Size by Application
7.3.1 Europe 3D Bioprinting Market Size by Application (2017-2022)
7.3.2 Europe 3D Bioprinting Market Size by Application (2023-2028)
7.3.3 Europe 3D Bioprinting Market Share by Application (2017-2028)
7.4 Europe 3D Bioprinting Market Size by Country
7.4.1 Europe 3D Bioprinting Market Size by Country (2017-2022)
7.4.2 Europe 3D Bioprinting Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific 3D Bioprinting Market Size (2017-2028)
8.2 Asia-Pacific 3D Bioprinting Market Size by Type
8.2.1 Asia-Pacific 3D Bioprinting Market Size by Type (2017-2022)
8.2.2 Asia-Pacific 3D Bioprinting Market Size by Type (2023-2028)
8.2.3 Asia-Pacific 3D Bioprinting Market Share by Type (2017-2028)
8.3 Asia-Pacific 3D Bioprinting Market Size by Application
8.3.1 Asia-Pacific 3D Bioprinting Market Size by Application (2017-2022)
8.3.2 Asia-Pacific 3D Bioprinting Market Size by Application (2023-2028)
8.3.3 Asia-Pacific 3D Bioprinting Market Share by Application (2017-2028)
8.4 Asia-Pacific 3D Bioprinting Market Size by Region
8.4.1 Asia-Pacific 3D Bioprinting Market Size by Region (2017-2022)
8.4.2 Asia-Pacific 3D Bioprinting Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America 3D Bioprinting Market Size (2017-2028)
9.2 Latin America 3D Bioprinting Market Size by Type
9.2.1 Latin America 3D Bioprinting Market Size by Type (2017-2022)
9.2.2 Latin America 3D Bioprinting Market Size by Type (2023-2028)
9.2.3 Latin America 3D Bioprinting Market Share by Type (2017-2028)
9.3 Latin America 3D Bioprinting Market Size by Application
9.3.1 Latin America 3D Bioprinting Market Size by Application (2017-2022)
9.3.2 Latin America 3D Bioprinting Market Size by Application (2023-2028)
9.3.3 Latin America 3D Bioprinting Market Share by Application (2017-2028)
9.4 Latin America 3D Bioprinting Market Size by Country
9.4.1 Latin America 3D Bioprinting Market Size by Country (2017-2022)
9.4.2 Latin America 3D Bioprinting Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa 3D Bioprinting Market Size (2017-2028)
10.2 Middle East & Africa 3D Bioprinting Market Size by Type
10.2.1 Middle East & Africa 3D Bioprinting Market Size by Type (2017-2022)
10.2.2 Middle East & Africa 3D Bioprinting Market Size by Type (2023-2028)
10.2.3 Middle East & Africa 3D Bioprinting Market Share by Type (2017-2028)
10.3 Middle East & Africa 3D Bioprinting Market Size by Application
10.3.1 Middle East & Africa 3D Bioprinting Market Size by Application (2017-2022)
10.3.2 Middle East & Africa 3D Bioprinting Market Size by Application (2023-2028)
10.3.3 Middle East & Africa 3D Bioprinting Market Share by Application (2017-2028)
10.4 Middle East & Africa 3D Bioprinting Market Size by Country
10.4.1 Middle East & Africa 3D Bioprinting Market Size by Country (2017-2022)
10.4.2 Middle East & Africa 3D Bioprinting Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Organovo Holdings Inc
11.1.1 Organovo Holdings Inc Company Details
11.1.2 Organovo Holdings Inc Business Overview
11.1.3 Organovo Holdings Inc 3D Bioprinting Introduction
11.1.4 Organovo Holdings Inc Revenue in 3D Bioprinting Business (2017-2022)
11.1.5 Organovo Holdings Inc Recent Developments
11.2 EnvisionTEC GmbH
11.2.1 EnvisionTEC GmbH Company Details
11.2.2 EnvisionTEC GmbH Business Overview
11.2.3 EnvisionTEC GmbH 3D Bioprinting Introduction
11.2.4 EnvisionTEC GmbH Revenue in 3D Bioprinting Business (2017-2022)
11.2.5 EnvisionTEC GmbH Recent Developments
11.3 Nano3D Biosciences, Inc
11.3.1 Nano3D Biosciences, Inc Company Details
11.3.2 Nano3D Biosciences, Inc Business Overview
11.3.3 Nano3D Biosciences, Inc 3D Bioprinting Introduction
11.3.4 Nano3D Biosciences, Inc Revenue in 3D Bioprinting Business (2017-2022)
11.3.5 Nano3D Biosciences, Inc Recent Developments
11.4 Cyfuse Biomedical K.K
11.4.1 Cyfuse Biomedical K.K Company Details
11.4.2 Cyfuse Biomedical K.K Business Overview
11.4.3 Cyfuse Biomedical K.K 3D Bioprinting Introduction
11.4.4 Cyfuse Biomedical K.K Revenue in 3D Bioprinting Business (2017-2022)
11.4.5 Cyfuse Biomedical K.K Recent Developments
11.5 Advanced Solutions, Inc
11.5.1 Advanced Solutions, Inc Company Details
11.5.2 Advanced Solutions, Inc Business Overview
11.5.3 Advanced Solutions, Inc 3D Bioprinting Introduction
11.5.4 Advanced Solutions, Inc Revenue in 3D Bioprinting Business (2017-2022)
11.5.5 Advanced Solutions, Inc Recent Developments
11.6 Aspect Biosystems Ltd
11.6.1 Aspect Biosystems Ltd Company Details
11.6.2 Aspect Biosystems Ltd Business Overview
11.6.3 Aspect Biosystems Ltd 3D Bioprinting Introduction
11.6.4 Aspect Biosystems Ltd Revenue in 3D Bioprinting Business (2017-2022)
11.6.5 Aspect Biosystems Ltd Recent Developments
11.7 3Dynamic Systems Ltd
11.7.1 3Dynamic Systems Ltd Company Details
11.7.2 3Dynamic Systems Ltd Business Overview
11.7.3 3Dynamic Systems Ltd 3D Bioprinting Introduction
11.7.4 3Dynamic Systems Ltd Revenue in 3D Bioprinting Business (2017-2022)
11.7.5 3Dynamic Systems Ltd Recent Developments
11.8 regenHU
11.8.1 regenHU Company Details
11.8.2 regenHU Business Overview
11.8.3 regenHU 3D Bioprinting Introduction
11.8.4 regenHU Revenue in 3D Bioprinting Business (2017-2022)
11.8.5 regenHU Recent Developments
11.9 Cellink
11.9.1 Cellink Company Details
11.9.2 Cellink Business Overview
11.9.3 Cellink 3D Bioprinting Introduction
11.9.4 Cellink Revenue in 3D Bioprinting Business (2017-2022)
11.9.5 Cellink Recent Developments
11.10 Regenovo Biotechnology Co., Ltd
11.10.1 Regenovo Biotechnology Co., Ltd Company Details
11.10.2 Regenovo Biotechnology Co., Ltd Business Overview
11.10.3 Regenovo Biotechnology Co., Ltd 3D Bioprinting Introduction
11.10.4 Regenovo Biotechnology Co., Ltd Revenue in 3D Bioprinting Business (2017-2022)
11.10.5 Regenovo Biotechnology Co., Ltd Recent Developments
11.11 Poietis
11.11.1 Poietis Company Details
11.11.2 Poietis Business Overview
11.11.3 Poietis 3D Bioprinting Introduction
11.11.4 Poietis Revenue in 3D Bioprinting Business (2017-2022)
11.11.5 Poietis Recent Developments
11.12 GeSiM
11.12.1 GeSiM Company Details
11.12.2 GeSiM Business Overview
11.12.3 GeSiM 3D Bioprinting Introduction
11.12.4 GeSiM Revenue in 3D Bioprinting Business (2017-2022)
11.12.5 GeSiM Recent Developments
11.13 Exone
11.13.1 Exone Company Details
11.13.2 Exone Business Overview
11.13.3 Exone 3D Bioprinting Introduction
11.13.4 Exone Revenue in 3D Bioprinting Business (2017-2022)
11.13.5 Exone Recent Developments
11.14 Stratasys
11.14.1 Stratasys Company Details
11.14.2 Stratasys Business Overview
11.14.3 Stratasys 3D Bioprinting Introduction
11.14.4 Stratasys Revenue in 3D Bioprinting Business (2017-2022)
11.14.5 Stratasys Recent Developments
11.15 Advanced BioMatrix
11.15.1 Advanced BioMatrix Company Details
11.15.2 Advanced BioMatrix Business Overview
11.15.3 Advanced BioMatrix 3D Bioprinting Introduction
11.15.4 Advanced BioMatrix Revenue in 3D Bioprinting Business (2017-2022)
11.15.5 Advanced BioMatrix Recent Developments
11.16 Ricoh Company Ltd
11.16.1 Ricoh Company Ltd Company Details
11.16.2 Ricoh Company Ltd Business Overview
11.16.3 Ricoh Company Ltd 3D Bioprinting Introduction
11.16.4 Ricoh Company Ltd Revenue in 3D Bioprinting Business (2017-2022)
11.16.5 Ricoh Company Ltd Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer